This article arises from Future Tense, a partnership of Slate, the New America Foundation, and Arizona State University that explores emerging technologies and their implications for public policy and for society. On Monday, Oct. 22, Future Tense will host “My Brain Made Me Do It,” an event in Washington, D.C., on how the legal system will adapt to changes in neuroscience. For more information and to RSVP, or to watch the live stream, visit the New America Foundation’s website.
If you read judicial opinions in serious crime cases, which always seem to describe every gruesome and salacious detail, you will almost surely reach two conclusions. First, no “normal” person could ever commit many of the horrific acts described in those cases. Second, everyone involved would be so much better off if we could have somehow anticipated and prevented those crimes from occurring in the first place. The perpetrators themselves might be leading normal lives if their violent tendencies were identified and treated before they committed their crimes. Even more importantly, the innocent victims, as well as their loved...
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
Today, Massachusetts Institute of Technology biologist Kevin Esvelt is well known for his work on guided evolution technologies—creating systems for evolving biomolecules in the lab and developing techniques to shape the evolutionary trajectories of species in the wild—as well as...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.